2012 Gastrointestinal Cancers Symposium - OncologySTAT
Links shared publicly online about this topic.
- 0total visits
2012 Gastrointestinal Cancers Symposium - OncologySTAT
View full resource at oncologystat.com
Most Recently Shared on February 2, 2012 at 5:20 pm By:
Read news from ASCO's 2012 Gastrointestinal Cancers Symposium! http://t.co/9NGPKXT2
Evidence mounts for link between opioids and cancer growth - The University of Chicago Medicine
uchospitals.edu — “March 21, 2012: Opioid drugs used to relieve pain in postoperative and chronic cancer patients may stimulate the growth and spread of tumors, according to two studies and a commentary in the 2012 annual Journal Symposium issue of Anesthesiology, the academic journal of the American Society of Anesthesiologists.” View full resource at uchospitals.edu
Most Recently Shared on March 22, 2012 at 6:05 pm By:
Ves Dimov, M.D. Internist, Allergist, Physician, and Doctor
Evidence mounts for link between opioids and cancer growth - drugs may stimulate growth and spread of tumors http://t.co/sMJAmCym
Dune Medical Devices Hosts Symposium Featuring MarginProbe® System at European Breast Cancer Conference - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: VIENNA, March 22, 2012 /PRNewswire/ -- Dune Medical Devices, the manufacturer of the MarginProbe ® System, held a satellite symposium featuring discussions with experts in the field of breast cancer regarding ...” View full resource at finance.yahoo.com
Most Recently Shared on March 22, 2012 at 12:55 pm By:
Dune Medical Devices Hosts Symposium Featuring MarginProbe® System at European Breast Cancer Conference: VIENNA,... http://t.co/QzPrhhor
Healthy Medicine Academy
healthymedicineacademy.com — “Healthy Medicine Academy” View full resource at healthymedicineacademy.com
Most Recently Shared on March 21, 2012 at 6:17 pm By:
Advances in Cancer Strategies Symposium, April 20-22, 2012 in Stamford, CT http://t.co/Igt5uLCB #bcsm #cancer
Evidence mounts for link between opioids and cancer growth
medicalxpress.com — “Opioid drugs used to relieve pain in postoperative and chronic cancer patients may stimulate the growth and spread of tumors, according to two studies and a commentary in the 2012 annual Journal Symposium issue of Anesthesiology, the academic journal of the American Society of Anesthesiologists.” View full resource at medicalxpress.com
Most Recently Shared on March 21, 2012 at 12:57 am By:
PhysOrg Health News Health News
Evidence mounts for link between opioids and cancer growth http://t.co/Nfbr22pl
How do you ensure best practice in colorectal cancer care? | Blog | Nursing Times
nursingtimes.net — “Article: Taylor C (2012) Best practice in colorectal cancer care. Nursing Times; 108: 12, xx-xx.Author: Claire Taylor is lecturer in gastrointestinal nursing, Florence Nightingale School of Nursing, King’s College London.Key pointsSome 40,000 new cases of colorectal cancer are dignosed in the UK every yearRisk factors ...” View full resource at nursingtimes.net
Most Recently Shared on March 19, 2012 at 9:42 am By:
How do you ensure best practice in colorectal cancer care? http://t.co/xPJt6vTH
ASCO Gastrointestinal Cancer Symposium 2012 « OncoFacts
oncofacts.com — “ASCO Gastrointestinal Cancer Symposium 2012 « OncoFacts” View full resource at oncofacts.com
Most Recently Shared on March 8, 2012 at 11:22 pm By:
Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: REDWOOD CITY, Calif., Jan. 20, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX - News) today announced positive results of the first clinical decision making study of the Oncotype DX® colon cancer test ...” View full resource at finance.yahoo.com
Most Recently Shared on January 20, 2012 at 4:16 pm By:
Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 20... http://t.co/DVneJsCX
Two Influential Colon Cancer Organizations Join Forces - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: SAN FRANCISCO -- The launch of the Global Colon Cancer Alliance (GCCA) was announced today at the ASCO Gastrointestinal Cancers Symposium in San Francisco, California. The newly formed alliance unites ...” View full resource at finance.yahoo.com
Most Recently Shared on January 19, 2012 at 6:45 pm By:
Two Influential Colon Cancer Organizations Join Forces: SAN FRANCISCO -- The launch of the Global Colon Cancer A... http://t.co/XOvzCWIM
Regorafenib lengthens lives of patients with metastatic colorectal cancer
news-medical.net — “An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.” View full resource at news-medical.net
Most Recently Shared on January 18, 2012 at 8:48 am By:
News-Medical.Net Health News and Oncology
Oncology News: Regorafenib lengthens lives of patients with metastatic colorectal cancer: An investigational dru... http://t.co/ouDJ5kWK
Cancer Research Institute
cri.bio.uci.edu — “Cancer Research Institute” View full resource at cri.bio.uci.edu
Most Recently Shared on December 12, 2011 at 3:39 pm By:
The 2012 Palm Springs Symposium on HIV/AIDS, "The Biology of HIV Infection", is March 8 - 11, 2012. This is an... http://t.co/lGtgU6pO
Dr. Alan P. Venook, MD, University of California San Francisco talks about neuroendocrine cancer at the ASCO 2011 Gastrointestinal Cancers Symposium
oncologytube.com — “Dr. Alan P. Venook, MD, University of California San Francisco talks about neuroendocrine cancer at the ASCO 2011 Gastrointestinal Cancers Symposium: Dr. Alan P. Venook, MD, University of California San Francisco talks about neuroendocrine cancer at the ASCO 2011 Gastrointestinal Cancers Symposium” View full resource at oncologytube.com
Most Recently Shared on April 21, 2011 at 5:12 pm By:
Sermo Team Health Social Media
Great info here: RT @oncologytube: #Oncology Neuroendocrine cancer http://bit.ly/gBUbvL #physicians #healthcare #education
Pathwork(R) Tissue Of Origin Test Clinical Utility Study Presented At ASCO GI Symposium
medicalnewstoday.com — “Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced that results from a decision impact study of its Tissue of Origin Test were presented this” View full resource at medicalnewstoday.com
Most Recently Shared on January 26, 2011 at 3:05 pm By:
MNT Gastrointestinal Health News
Pathwork(R) Tissue Of Origin Test Clinical Utility Study Presented At ASCO GI Symposium http://mnt.to/3QrM #gastrointestinal
Phase 1 Results Of ARQ 197 C-MET Inhibitor In Colorectal Cancer Presented At ASCO 2011 Gastrointestinal Cancers Symposium
medicalnewstoday.com — “ArQule, Inc. (NASDAQ: ARQL) announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecul” View full resource at medicalnewstoday.com
Most Recently Shared on January 26, 2011 at 2:05 pm By:
MNT Colorectal Canc Health News
Phase 1 Results Of ARQ 197 C-MET Inhibitor In Colorectal Cancer Presented At ASCO 2011 Gastrointestinal Cancers Symposium http://mnt.to/3QrP
Kowa Announces Subgroup Analyses of Peretinoin (NIK-333) Phase II/III Trial in Patients Following Curative Therapy for Hepatocellular Carcinoma (HCC) Indicate Populations Who May Gain Most Benefit from Peretinoin Therapy - Drugs.com MedNews
drugs.com — “Peretinoin may reduce de novo carcinogenesis Presented at American Society of Clinical Oncology Gastrointestinal Cancers Symposium 2011 Jan 24, 2011 - Kowa Comp” View full resource at drugs.com
Most Recently Shared on January 24, 2011 at 2:10 pm By:
Drugs and Devices OW OW Health
Kowa Announces Subgroup Analyses of Peretinoin (NIK-333) Phase II/III Trial in Patients Following Curative... http://bit.ly/eTUeA7 #drug
Phase 1 Results of ARQ 197 c-MET Inhibitor in Colorectal Cancer Presented at ASCO 2011 Gastrointestinal Cancers Symposium - Drugs.com MedNews
drugs.com — “Jan 24, 2011 - ArQule, Inc. (NASDAQ ARQL) today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal canc” View full resource at drugs.com
Most Recently Shared on January 24, 2011 at 2:10 pm By:
Drugs and Devices OW OW Health
Phase 1 Results of ARQ 197 c-MET Inhibitor in Colorectal Cancer Presented at ASCO 2011 Gastrointestinal Ca... http://bit.ly/i4pND3 #drug
Advertisement
